Meng-Meng Ji - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

International Journal of Biological Sciences|August 8, 2024

KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axisQing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.

Genome Medicine|May 1, 2020

CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.

Molecular Biomedicine|December 9, 2025

Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

International Journal of Biological Sciences|August 8, 2024

KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axisQing-Xiao Liu, Yue Zhu, Hong-Mei Yi, et al.

Genome Medicine|May 1, 2020

CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.

Molecular Biomedicine|December 9, 2025

Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.

Pageof 3